Press Releases

March 26th, 2020

Service will provide next day direct-to-home delivery to medical cannabis patients Initial launch in Greater Golden Horseshoe Region, centred around Toronto, with a population of over 9 million  Mitigates risk of using postal service and third-party parcel delivery which may be disrupted during COVID-19 pandemic TORONTO, March 26, 2020 – Aleafia Health Inc. (TSX: ALEF, […]

March 18th, 2020

First quarterly positive adjusted EBITDA of $0.2M in Q4 2019 27% increase in Q4 2019 net cannabis revenue over the previous quarter 1,748% increase in FY 2019 net cannabis revenue over the previous year Gross margin on cannabis net revenue of 80% in Q4 2019 Q4 2019 SG&A expenses of $4.3 million, a decrease of […]

March 16th, 2020

TORONTO, March 16, 2020 – Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) wholly owned subsidiary, Aleafia Farms Inc., has secured a Health Canada Cultivation Licence (the “Licence”) for the Company’s Niagara Production Facility (the “Niagara Facility”), located in Grimsby, Ont. SEE MORE NIAGARA FACILITY PHOTOS “This is an important and […]

February 25th, 2020

TORONTO – February 25, 2020 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2019 fourth quarter and fiscal year results on March 18, 2020 prior to market open. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will […]

January 24th, 2020

TORONTO, January 24, 2020 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), a global cannabis health and wellness company, is pleased to announce that it has become a constituent company of the newly launched S&P/MX International Cannabis Index (MCAN). S&P Dow Jones calculates and manages the S&P/MX Indices. […]

January 16th, 2020

Kin Slips™, award-winning cannabis infused sublingual strips with a 10-minute onset time, are currently produced and sold under license exclusively in California Agreement provides exclusive Canadian rights to Aleafia Health to manufacture, market and sell Kin Slips, using proprietary formulations, manufacturing methodology and intellectual property Kin Slips will be launched in medical and adult-use markets  […]

December 10th, 2019

Five innovative cannabis education courses will be available to students in January 2020 Toronto, Dec. 10, 2019 – Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) cannabis education division, FoliEdge Academy Inc., has entered into a definitive Educational Products Distribution Agreement with Seneca to develop and deliver new courses […]

December 2nd, 2019

TORONTO, December 2, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has reached a definitive Cannabis Material Purchase Agreement (the “Agreement”) on November 29, 2019, with a Canadian Licensed Producer. Under the terms of the Agreement, Aleafia Health will sell 2,840 kg of dried cannabis flower at […]

November 28th, 2019

TORONTO, November 28, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has completed production of its first white label production run of medical cannabis oils, for distribution in Australia. The cannabis oils were produced at the Company’s Paris Processing Facility and will be distributed by Melbourne, Australia […]

November 19th, 2019

TORONTO, November 19, 2019 – Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly-owned subsidiary FoliEdge Academy, has entered into an Educational Products Distribution Agreement with one of the largest Canadian post-secondary institutions to introduce cannabis education courses and programs. The partner institution announcement and courses launch will occur […]

November 14th, 2019

Health Canada licence amendment doubles licensed processing area  Company can also now produce and sell edibles, topicals and extracts Final site evidence package for Paris Phase II expansion has been submitted TORONTO, November 14, 2019 – Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) wholly owned subsidiary, Emblem Cannabis […]

November 12th, 2019

Ultra low-cost production at $0.08 cost per gram at outdoor facility Average net revenue per gram equivalent of $15.11 for medical cannabis sales Medical cannabis sales up 43% Q/Q, adult-use cannabis sales up 53% Q/Q Active, registered medical cannabis patients increase 48% Q/Q $57M in cash/marketable securities, $83M in working capital Total expenses decrease 30% […]

November 11th, 2019

Cannabinoid content per gram only slightly lower than identical strains grown indoors Critical quality control tests successful Approximately 1,000 kg yield per acre in Zone 1 Expanded 3.7M sq. ft. outdoor site expected to produce approximately 102,000 kg in 2020 at full capacity TORONTO, November 11, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, […]

October 23rd, 2019

TORONTO — October 23, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF) (“Aleafia Health” or the “Company”) will announce its 2019 Third Quarter Financial Results on November 12, 2019 prior to market open. The Company will also host its Third Quarter Results Call the same day at 8:30 a.m. EST. The call will be […]

October 8th, 2019

TORONTO, October 8, 2019 – Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announces that it has provided Aphria Inc. (TSX: APHA, NYSE: APHA) (“Aphria”) with a formal notice of the termination, effective October 7, 2019, of the wholesale cannabis supply agreement (the “Supply Agreement”) dated September 11, 2018 […]